rends in target markets; and
its assessment of consumer demands for various applications. Synaptics
cautions that these statements are qualified by important factors that
could cause actual results to differ materially from those reflected by the
forward-looking statements contained herein. Such factors include, but are
not limited to, (a) demand for Synaptics' products, (b) market demand for
OEMs' products using Synaptics' solutions, (c) changing market demand
trends in the markets it serves, and (d) other risks as identified from
time to time in Synaptics' SEC reports, including Quarterly Reports on Form
10-Q and the Annual Report on Form 10-K for the fiscal year ended June 30,
2008. All forward-looking statements are based on information available to
Synaptics on the date hereof, and Synaptics assumes no obligation to update
such statements.
(Tables to Follow)
SYNAPTICS INCORPORATED
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
September 30, June 30,
2008 2008
Assets
Current assets:
Cash and cash equivalents $112,063 $96,218
Short term investments 40,427 50,298
Total cash, cash equivalents,
and short-term investments 152,490 146,516
Receivables, net of allowances of
$539 and $539, respectively 86,598 69,362
Inventories 25,138 21,065
Prepaid expenses and other current
assets 3,853 3,417
Total current assets 268,079 240,360
Property and equipmen
'/>"/>
SOURCE Synaptics Incorporated Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology news :1.
Synaptics to Report First Quarter Results on October 232.
Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree3.
GEN reports on novel tools for deciphering biological networks4.
Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics5.
LSUHSC research reports new method to protect brain cells from diseases like Alzheimers6.
Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results7.
BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 20088.
BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 20089.
Limiting fructose may boost weight loss, UT Southwestern researcher reports10.
Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery11.
BIO-key(R) Reports First Quarter 2008 Results